fda warning letters glp-1 september 2025 news Beyond the Headlines: to Compounders FDA Issues 30 Warning Letters
Description
Whats Emerging in Practice Outside of Trials GLP-1s live in the wildprescribed broadly, dosed variably, and sometimes obtained without medical oversight
& Silvestre, L
Injectable formulations like Ozempic, Trulicity, and Mounjaro are widely prescribed, with user-friendly pen devices enhancing patient compliance
Most of them were not on nephroprotective drugs such as SGLT-2 inhibitors (75%) and mineralocorticoid receptor antagonists (92%), while 81% of patients were on ACE-I or ARBs [49]
Gastric emptying is now recognized as a major determinant of postprandial glycemic excursions in both healthy subjects (6) and people with diabetes (7) and accounts for about a third of the variance in the initial rise in glucose postoral challenge (ie, first 15-30 minutes) (6)
Contact the Ozempic lawyers at TorHoerman Law for a free consultation
